TheAnswerPage.com launches CME course on cannabis complications

By AI, Created 5:10 AM UTC, May 20, 2026, /AGP/ – TheAnswerPage.com has introduced a new 2-credit CME/CE course aimed at helping clinicians identify and manage cannabis use disorder and cannabinoid hyperemesis syndrome. The launch comes as cannabis use expands and more providers encounter related complications in everyday practice.

Why it matters: - Cannabis use is becoming more common across U.S. clinical settings, and more clinicians are seeing patients with cannabis-related complications. - The new course is designed to give healthcare professionals practical guidance on two conditions that can affect diagnosis, treatment, and patient counseling. - TheAnswerPage.com is positioning the course as part of a broader push for cannabis education that goes beyond cannabinoid pharmacology and therapeutic use.

What happened: - TheAnswerPage.com launched a new multi-accredited 2-credit CME/CE course called “Cannabis Use Disorder and Cannabinoid Hyperemesis Syndrome.” - The course is now available through the company’s course page. - The release was announced in Boston on May 20, 2026. - The course is aimed at physicians, nurses, nurse practitioners, pharmacists, physician assistants and other healthcare professionals.

The details: - The curriculum covers diagnostic criteria and clinical presentation of cannabis use disorder. - The course addresses tolerance, cannabis withdrawal, craving and impaired control of cannabis use. - It includes recognition and management of cannabinoid hyperemesis syndrome. - The material also covers treatment strategies and relapse prevention approaches. - Case-based clinical scenarios are included to reinforce key concepts. - The course includes communication strategies for discussing cannabis use with patients. - TheAnswerPage.com says the program is intended for clinicians across all specialties who care for patients affected by cannabis use. - Stephen B. Corn, MD, said clinicians need practical guidance on both potential therapeutic applications of cannabis and related complications such as cannabis use disorder and cannabinoid hyperemesis syndrome. - Meredith Fisher-Corn, MD, said she has seen growing interest from state health departments and healthcare organizations in clinician education on these conditions. - TheAnswerPage.com said the new course complements its recently launched 4-credit CME/CE course, “Cannabis and Cannabinoids in Clinical Practice,” and its 6-credit bundle, “Cannabis Medicine: A Comprehensive Clinical Guide.”

Between the lines: - The launch reflects how cannabis education is shifting from general medical cannabis knowledge toward everyday clinical management of side effects and misuse. - The release also suggests demand is growing for short, practical courses that can be used across multiple specialties and settings. - The emphasis on evidence-based, patient-centered education signals a market for training that is more clinical and less promotional.

What’s next: - TheAnswerPage.com is likely to keep expanding cannabis-related clinician education as state-level and institutional demand continues. - The company said it works with departments of health, medical associations, hospital systems and other healthcare organizations to meet evolving educational needs. - The release highlights TheAnswerPage.com’s longer-term role in required or state-aligned cannabis education in multiple U.S. jurisdictions.

The bottom line: - TheAnswerPage.com is betting that clinicians need more than cannabis basics — they need practical training on the complications showing up in real-world care.